Patents: From Invention to Commercialization in the Biomedical Space
The Office of Technology Commercialization
Presents
Invention 2 Innovation (I2I)
Patents: From Invention to Commercialization in the Biomedical Space
Wed., April 17, 2019
12:00 pm – 1:30 pm
Building D, Warwick Evans Conference Room (New Location)
Presented By

Dr. Ling Zhong, Ph.D., Shareholder

Mr. James M. Gould, Counsel
Ratner Prestia
Recent legal developments are having a profound effect on critical patent issues in the biomedical space. This seminar will cover the latest trends and strategies including:
- Patentability issues associated with inventions relating to biomarkers, diagnostics, new uses of known drugs, new formulations of known drugs, new dosage regimes, and new combinations
- The interplay between patent-based exclusivity and the various FDA-based exclusivities
- Patent issues arising from collaboration between inventors and sponsors of clinical trials